Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial sulfur-containing and disulfide-bonded proteins constitute a diverse and essential class of molecules required for the survival, structural integrity, and pathogenicity of bacteria, fungi, and viruses. These proteins rely on the reactive properties of sulfur-containing amino acids, primarily cysteine and methionine, to form disulfide bridges that stabilize protein tertiary and quaternary structures, particularly in the harsh extracytoplasmic environment (Heras et al., 2015, Nature Reviews Microbiology). In many bacterial pathogens, the Disulfide Bond (Dsb) system—including enzymes like DsbA and DsbB—is responsible for catalyzing the formation of these bonds, which are critical for the functional assembly of toxins, adhesins, and secretion systems (Landeta et al., 2018, Nature Communications). From a therapeutic perspective, these proteins are targeted by a variety of antimicrobial agents that exploit the high affinity of sulfur for certain metals and oxidants. For example, silver ions ($Ag^+$) exert potent antimicrobial effects by binding to thiol groups, leading to the denaturation of essential enzymes and the disruption of the microbial respiratory chain (Jung et al., 2008, Applied and Environmental Microbiology). Additionally, novel small-molecule inhibitors are being developed to specifically target the Dsb machinery as an anti-virulence strategy, aiming to disarm pathogens without necessarily killing them, which may reduce the selective pressure for antibiotic resistance (Halili et al., 2015, Journal of Molecular Biology).
Drugs targeting these proteins typically act via the oxidation of sulfhydryl (thiol) groups, the formation of stable metal-mercaptide complexes, or the competitive inhibition of enzymes like DsbA and DsbB that catalyze disulfide bond formation, thereby preventing the correct folding of essential microbial proteins and virulence factors (Heras et al., 2015, Nature Reviews Microbiology; Jung et al., 2008, Applied and Environmental Microbiology).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial sulfur-containing and disulfide-bonded proteins.